Literature DB >> 9058240

Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

J Gutiérrez1, M Rodríguez, C Maroto, G Piédrola.   

Abstract

We studied the reliability of new indirect tests in the diagnosis of acute infection by Epstein-Barr virus (EBV). Studied for all samples were method 1, the heterophil antibodies (Abs) (Monolatex, Biokit, Germany); method 2, the IgM Abs to EBV with ELISA tests (antigen pools, Enzygnost, Behring-werke, Germany); method 3, EA (Biotest Diagnostics, Germany); and method 4, the IgG avidity test. The reliability of the four tests for the detection of primary infection by EBV was: sensitivity (method 1: 89.1%; method 2: 100%; method 3: 79.7%; method 4: 99%); specificity (method 1: 98%; method 2: 100%; method 3: 84%; method 4: 100%); positive predictive value (method 1: 97.6%; method 2: 100%; method 3: 73.6%; method 4: 100%), and negative predictive value (method 1: 90.7%; method 2: 100%; method 3: 84%; method 4: 99%). The IgG avidity test (method 4) is simple and automated in the laboratory and is very useful for ascertaining, from a single sample, the time since infection. It is criteria of recent primoinfection higher levels than 55% of IgG with low avidity for the antigen. The investigation of the Abs to antigen pools (method 2) by ELISA of virus had a high reliability, but the investigation of heterophil Abs by latex (method 1) and the Abs IgM to EA (method 2) were lacking in sensibility regarding their use in the diagnosis of the primoinfection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058240      PMCID: PMC6760749     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  28 in total

1.  [Acute infections caused by Epstein-Barr virus. Comparative study of various diagnostic methods].

Authors:  J Gutiérrez; G Piédrola; M C Maroto
Journal:  Rev Clin Esp       Date:  1992-10       Impact factor: 1.556

2.  Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever.

Authors:  D Guigno; B Coupland; E G Smith; I D Farrell; U Desselberger; E O Caul
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Evaluation of the avidity of IgG anti-mycobacterial antibodies in tuberculous patients serum by an A-60 immunoassay.

Authors:  R F Maes
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

4.  Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens.

Authors:  D L Wiedbrauk; S Bassin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  False positivity of IGM antibody to Epstein-Barr viral capsid antigen during acute hepatitis A infection.

Authors:  C R Fikar; C McKee
Journal:  Pediatr Infect Dis J       Date:  1994-05       Impact factor: 2.129

6.  Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.

Authors:  N K Blackburn; T G Besselaar; B D Schoub; K F O'Connell
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

7.  Low antibody avidity in elderly chickenpox patients.

Authors:  B D Schoub; N K Blackburn; S Johnson; J M McAnerney; B Miller
Journal:  J Med Virol       Date:  1992-06       Impact factor: 2.327

8.  Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses.

Authors:  K N Ward; J J Gray; M E Joslin; M J Sheldon
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

9.  IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection.

Authors:  K N Ward; J J Gray; M W Fotheringham; M J Sheldon
Journal:  J Med Virol       Date:  1993-02       Impact factor: 2.327

10.  Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology.

Authors:  H I Thomas; P Morgan-Capner; J E Cradock-Watson; G Enders; J M Best; S O'Shea
Journal:  J Med Virol       Date:  1993-11       Impact factor: 2.327

View more
  1 in total

1.  Clinical reliability of IgG, IgA, and IgM antibodies in detecting Epstein-Barr virus at different stages of infection with a commercial nonrecombinant polyantigenic ELISA.

Authors:  J Gutiérrez; M J Vergara; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.